- Home
- ZBRA vs SNN Comparison
ZBRA vs SNN Comparison
Compare ZBRA & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBRA
- SNN
- Stock Information
- Founded
- ZBRA 1969
- SNN 1856
- Country
- ZBRA United States
- SNN United Kingdom
- Employees
- ZBRA N/A
- SNN N/A
- Industry
- ZBRA Industrial Machinery/Components
- SNN Industrial Specialties
- Sector
- ZBRA Industrials
- SNN Health Care
- Exchange
- ZBRA Nasdaq
- SNN Nasdaq
- Market Cap
- ZBRA 15.0B
- SNN 12.3B
- IPO Year
- ZBRA 1991
- SNN 1999
- Fundamental
- Price
- ZBRA $280.79
- SNN $28.05
- Analyst Decision
- ZBRA Buy
- SNN Hold
- Analyst Count
- ZBRA 11
- SNN 3
- Target Price
- ZBRA $382.00
- SNN $27.00
- AVG Volume (30 Days)
- ZBRA 568.9K
- SNN 744.3K
- Earning Date
- ZBRA 04-29-2025
- SNN 02-25-2025
- Dividend Yield
- ZBRA N/A
- SNN 2.62%
- EPS Growth
- ZBRA 77.97
- SNN 56.15
- EPS
- ZBRA 10.18
- SNN 0.47
- Revenue
- ZBRA $4,981,000,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- ZBRA $7.95
- SNN $6.42
- Revenue Next Year
- ZBRA $6.06
- SNN $5.03
- P/E Ratio
- ZBRA $27.54
- SNN $29.40
- Revenue Growth
- ZBRA 8.66
- SNN 4.70
- 52 Week Low
- ZBRA $266.75
- SNN $23.65
- 52 Week High
- ZBRA $427.76
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- ZBRA 35.40
- SNN 48.82
- Support Level
- ZBRA $280.25
- SNN $27.83
- Resistance Level
- ZBRA $301.77
- SNN $28.71
- Average True Range (ATR)
- ZBRA 7.56
- SNN 0.43
- MACD
- ZBRA 3.06
- SNN -0.21
- Stochastic Oscillator
- ZBRA 31.75
- SNN 10.14
About ZBRA Zebra Technologies Corporation
Zebra Technologies is a leading provider of automatic identification and data capture technology to enterprises. Its solutions include barcode printers and scanners, mobile computers, and workflow optimization software. The firm primarily serves the retail, transportation logistics, manufacturing, and healthcare markets, designing custom solutions to improve efficiency at its customers.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.